Cornea Sense is developing a medical diagnostic device to help eye doctors diagnose and monitor ophthalmic and metabolic diseases by providing direct and specific ocular surface hydration data.
https://corneasense.com/ has raised €1.1M across 1 funding round from 5 investors, most recently a Pre-Seed round in Jul 2026. Based in Espoo, Finland; active in Healthtech. Data as of 15 Jul 2026.
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-07-15 | Pre-Seed | €1.1M |
| Angel Investors,Business Finland R&D,Innovestor Angel CoFund,Matts Linder,Patrick Aisher |
| View deal → |
